Human Embryonic Stem Cell-Derived Retinal Pigment Epithelial Cells clinical trials

A Safety Surveillance Study in Subjects With Macular Degenerative Disease Treated With Human Embryonic Stem Cell-derived Retinal Pigment Epithelial Cell Therapy

This study is checking on the safety of an older treatment for macular disease that used special cells. It's looking for any problems that might appear many years after the treatment, especially in people who had it in a previous trial.